计划Act:一个基于eclipse脚本API的模块,嵌入了用于本地高级非小细胞肺癌自动规划的临床优化策略
Hao Guo1, Tenzin Kunkyab1, Yang Lei1
1Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, USA.
Journal of applied clinical medical physics
|October 9, 2025
概括
"PlanAct"显著改善了对非小细胞肺癌的自动化强度调节放射治疗计划,优于现有方法,并提供更好的风险器官节约. 这种工具可以提高治疗的一致性和质量,以应对具有挑战性的病例.
科学领域:
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
- 癌症治疗方法 癌症治疗方法
背景情况:
- 针对局部晚期非小细胞肺癌 (LA-NSCLC) 的手动强度调节放射治疗 (IMRT) 计划是资源密集的.
- 像RapidPlan这样的现有自动化方法通常需要对LA-NSCLC进行手动调整以达到临床目标.
研究的目的:
- 开发和验证PlanAct,一个基于Eclipse脚本API (ESAPI) 的模块,用于LA-NSCLC的自动IMRT规划.
- 将PlanAct的表现与RapidPlan和现有的临床计划进行比较.
主要方法:
- 计划Act是开发的模块化功能,以自动化IMRT计划生成和优化.
- 在56个追溯的LA-NSCLC案件中执行,使用机构质量指标对RapidPlan和临床基准进行计划评估.
- 统计分析评估了计划质量和满足剂量测量要求的差异.
主要成果:
- 与RapidPlan相比,与PlanAct优化的计划显示出更高的质量和更好的风险器官节省,特别是肺部 (p <0.001对于V20和Dmean),相比RapidPlan.
- 与PlanAct (1项计划) 相比,RapidPlan (18项计划) 和临床计划 (10项计划) 的未满足临床需求显著减少.
- 即使在复杂的解剖病例中,PlanAct也表现出卓越的剂量分布和热点控制.
结论:
- 计划Act是优化LA-NSCLC中自动化IMRT规划的有效工具.
- 实现与临床标准相美或优于临床标准的计划,即使在具有挑战性的患者病例中也是如此.
- 它的模块化设计显示了将其集成到未来的自主,针对患者的放射治疗规划系统中的潜力.
关键词:
基于知识的规划是基于知识的.相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Planning Nursing Care I
5.5K
The planning phase of the nursing process helps nurses set priorities, outline patient-centered goals and expected outcomes, and tailor nursing interventions to align with the aligned care plan. Through the planning phase, the nurse applies critical thinking skills to align and develop interventions according to the patient's needs. It provides continuity of care allowing patients to receive the maximum benefit from treatment. It serves as a pilot plan for allocating individual staff to a...
5.5K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K


